• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可溶性CD14-亚型前降钙素(sCD14-ST)对入住医院重症监护病房(ICU)患者的诊断及预后价值

Diagnostic and prognostic value of sCD14-ST--presepsin for patients admitted to hospital intensive care unit (ICU).

作者信息

Godnic Matej, Stubljar David, Skvarc Miha, Jukic Tomislav

机构信息

Novo mesto General Hospital, Novo mesto, Slovenia.

出版信息

Wien Klin Wochenschr. 2015 Jul;127(13-14):521-7. doi: 10.1007/s00508-015-0719-5. Epub 2015 Apr 9.

DOI:10.1007/s00508-015-0719-5
PMID:25854904
Abstract

BACKGROUND

Sepsis is a serious problem in intensive care units all over the world. Biomarkers could be useful to identify patients at risk. We focused especially on the performance of presepsin (sCD14-ST), compared to C-reactive protein (CRP), procalcitonin (PCT) and CD64, to determine its diagnostic and prognostic indications.

METHODS

The study was conducted on 47 hospitalized patients after procedures, who were divided into three groups; systemic inflammatory response (SIRS), sepsis and septic shock. Expression of CD64 on neutrophils presented as CD64 index, sCD14-ST, CRP and PCT were measured in whole blood or plasma samples. All patients had standard samples like urine, respiratory tract samples etc. taken for culturing. Blood cultures were drawn to confirm bloodstream infection.

RESULTS

Forty (85 %) patients had SIRS with bacterial infection and seven (15 %) patients had SIRS with no infection. All infections were confirmed with blood cultures. Biomarkers were evaluated in all patients. In patients with confirmed infection the values were high. The patients with bacterial infection showed statistical significance with CD64 index (p = 0.003), CRP (p = 0.049) and sCD14-ST (p = 0.026), but not with PCT (p = 1.000). The severity of diagnosed SIRS was significant only with PCT (p < 0.001).

CONCLUSION

CD64 index, CRP and sCD14-ST served as good parameters to determine possible infection in patients that needed intensive care after major procedures. Values of PCT were the only ones to predict SIRS severity and could distinguish between sepsis and severe sepsis or septic shock.

摘要

背景

脓毒症是全球重症监护病房面临的一个严重问题。生物标志物有助于识别有风险的患者。我们特别关注可溶性髓系细胞触发受体-1(sCD14-ST)与C反应蛋白(CRP)、降钙素原(PCT)和CD64相比的性能,以确定其诊断和预后指征。

方法

对47例术后住院患者进行了研究,这些患者被分为三组:全身炎症反应(SIRS)、脓毒症和感染性休克。在全血或血浆样本中测量中性粒细胞上CD64的表达(以CD64指数表示)、sCD14-ST、CRP和PCT。所有患者均采集了尿液、呼吸道样本等标准样本进行培养。采集血培养以确认血流感染。

结果

40例(85%)患者发生伴有细菌感染的SIRS,7例(15%)患者发生无感染的SIRS。所有感染均经血培养确诊。对所有患者的生物标志物进行了评估。在确诊感染的患者中,这些值较高。细菌感染患者的CD64指数(p = 0.003)、CRP(p = 0.049)和sCD14-ST(p = 0.026)有统计学意义,但PCT无统计学意义(p = 1.000)。仅PCT与确诊SIRS的严重程度有显著相关性(p < 0.001)。

结论

CD64指数、CRP和sCD14-ST是确定大手术后需要重症监护的患者是否可能感染的良好参数。PCT值是预测SIRS严重程度的唯一指标,并且可以区分脓毒症与严重脓毒症或感染性休克。

相似文献

1
Diagnostic and prognostic value of sCD14-ST--presepsin for patients admitted to hospital intensive care unit (ICU).可溶性CD14-亚型前降钙素(sCD14-ST)对入住医院重症监护病房(ICU)患者的诊断及预后价值
Wien Klin Wochenschr. 2015 Jul;127(13-14):521-7. doi: 10.1007/s00508-015-0719-5. Epub 2015 Apr 9.
2
Soluble CD14 subtype (sCD14-ST) presepsin in premature and full term critically ill newborns with sepsis and SIRS.患有脓毒症和全身炎症反应综合征的早产及足月危重新生儿中的可溶性CD14亚型(sCD14-ST)前降钙素。
Clin Chim Acta. 2015 Dec 7;451(Pt A):65-70. doi: 10.1016/j.cca.2015.07.025. Epub 2015 Jul 29.
3
Presepsin (sCD14-ST) in preoperative diagnosis of abdominal sepsis.术前诊断腹腔感染中可溶性 CD14 亚型(sCD14-ST)的作用。
Clin Chem Lab Med. 2013 Oct;51(10):2053-62. doi: 10.1515/cclm-2013-0061.
4
Usefulness of several biomarkers in the management of septic patients: C-reactive protein, procalcitonin, presepsin and mid-regional pro-adrenomedullin.几种生物标志物在脓毒症患者管理中的作用:C 反应蛋白、降钙素原、前降钙素原和肾上腺髓质中段肽。
Clin Chem Lab Med. 2016 Jan;54(1):163-8. doi: 10.1515/cclm-2015-0243.
5
Presepsin is an early monitoring biomarker for predicting clinical outcome in patients with sepsis.血清淀粉样蛋白前体是预测脓毒症患者临床结局的早期监测生物标志物。
Clin Chim Acta. 2016 Sep 1;460:93-101. doi: 10.1016/j.cca.2016.06.030. Epub 2016 Jun 25.
6
Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction.全身炎症反应综合征、脓毒症及器官功能障碍时的降钙素原和C反应蛋白
Crit Care. 2004 Aug;8(4):R234-42. doi: 10.1186/cc2877. Epub 2004 Jun 10.
7
Daily monitoring of biomarkers of sepsis in complicated long-term ICU-patients: can it support treatment decisions?对复杂长期 ICU 患者的脓毒症生物标志物进行日常监测:能否支持治疗决策?
Minerva Anestesiol. 2010 Oct;76(10):814-23. Epub 2010 Jul 1.
8
Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock.降钙素原用于全身炎症反应综合征、脓毒症、严重脓毒症及脓毒性休克的早期诊断与鉴别。
Intensive Care Med. 2000 Mar;26 Suppl 2:S148-52. doi: 10.1007/BF02900728.
9
[Procalcitonin for the differential diagnosis of infectious and non-infectious systemic inflammatory response syndrome after cardiac operation].[降钙素原用于心脏手术后感染性与非感染性全身炎症反应综合征的鉴别诊断]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2014 Jul;26(7):478-9.
10
Comparison of Fcγ receptor expression on neutrophils with procalcitonin for the diagnosis of sepsis in critically ill patients.比较中性粒细胞 Fcγ 受体表达与降钙素原对危重症患者脓毒症的诊断价值。
Respirology. 2011 Jan;16(1):152-60. doi: 10.1111/j.1440-1843.2010.01876.x.

引用本文的文献

1
Presepsin in Critical Illness: Current Knowledge and Future Perspectives.危重症中的前降钙素:当前认知与未来展望。
Diagnostics (Basel). 2024 Jun 20;14(12):1311. doi: 10.3390/diagnostics14121311.
2
Study of Phospholipase A2 Levels and Its Comparison With Procalcitonin Levels in Patients With Sepsis Admitted in a Tertiary Care Hospital, Karnataka, India.印度卡纳塔克邦一家三级护理医院收治的脓毒症患者中磷脂酶A2水平的研究及其与降钙素原水平的比较。
Cureus. 2023 Dec 21;15(12):e50890. doi: 10.7759/cureus.50890. eCollection 2023 Dec.
3
Presepsin as a diagnostic marker of sepsis in children and adolescents: a short critical update.

本文引用的文献

1
Presepsin as a potential marker for bacterial infection relapse in critical care patients. A preliminary study.前降钙素作为危重症患者细菌感染复发的潜在标志物:一项初步研究。
Clin Chem Lab Med. 2015 Mar;53(4):567-73. doi: 10.1515/cclm-2014-0119.
2
Diagnostic accuracy of presepsin (soluble CD14 subtype) for prediction of bacteremia in patients with systemic inflammatory response syndrome in the Emergency Department.急诊科中可溶性CD14亚型前降钙素对全身炎症反应综合征患者菌血症预测的诊断准确性
Clin Biochem. 2014 May;47(7-8):505-8. doi: 10.1016/j.clinbiochem.2014.02.011. Epub 2014 Feb 20.
3
Non-culture-based methods to diagnose bloodstream infection: Does it work?
血清淀粉样蛋白前体作为儿童和青少年脓毒症的诊断标志物:简短的批判性更新。
Acta Biomed. 2023 Jun 14;94(3):e2023062. doi: 10.23750/abm.v94i3.13358.
4
Current Status of Antibiotic Stewardship and the Role of Biomarkers in Antibiotic Stewardship Programs.抗生素管理的现状及生物标志物在抗生素管理计划中的作用
Infect Chemother. 2022 Dec;54(4):674-698. doi: 10.3947/ic.2022.0172.
5
Evaluation of sTREM1 and suPAR Biomarkers as Diagnostic and Prognostic Predictors in Sepsis Patients.评估可溶性髓系细胞触发受体-1(sTREM1)和可溶性尿激酶型纤溶酶原激活物受体(suPAR)生物标志物在脓毒症患者中的诊断和预后预测价值。
Infect Drug Resist. 2021 Aug 31;14:3495-3507. doi: 10.2147/IDR.S314237. eCollection 2021.
6
Presepsin as Early Marker of Sepsis in Emergency Department: A Narrative Review.降钙素原作为急诊科脓毒症早期标志物:一项叙述性综述。
Medicina (Kaunas). 2021 Jul 29;57(8):770. doi: 10.3390/medicina57080770.
7
Usefulness of sialic acid for diagnosis of sepsis in critically ill patients: a retrospective study.唾液酸对危重症患者脓毒症诊断的作用:一项回顾性研究。
BMC Anesthesiol. 2020 Nov 3;20(1):277. doi: 10.1186/s12871-020-01197-2.
8
An Update on Sepsis Biomarkers.脓毒症生物标志物的最新进展
Infect Chemother. 2020 Mar;52(1):1-18. doi: 10.3947/ic.2020.52.1.1.
9
Presepsin level in predicting patients' in-hospital mortality from sepsis under sepsis-3 criteria.基于脓毒症-3标准,前降钙素水平在预测脓毒症患者院内死亡率中的作用
Ther Clin Risk Manag. 2019 Jun 13;15:733-739. doi: 10.2147/TCRM.S209710. eCollection 2019.
10
Diagnostic value of procalcitonin and presepsin for sepsis in critically ill adult patients: a systematic review and meta-analysis.降钙素原和可溶性髓系细胞触发受体-1对危重症成年患者脓毒症的诊断价值:一项系统评价和荟萃分析
J Intensive Care. 2019 Apr 15;7:22. doi: 10.1186/s40560-019-0374-4. eCollection 2019.
非基于培养的血流感染诊断方法:可行吗?
Eur J Microbiol Immunol (Bp). 2013 Jun;3(2):97-104. doi: 10.1556/EuJMI.3.2013.2.2. Epub 2013 Jun 5.
4
Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department.急诊室中普雷斯帕辛对脓毒症的诊断价值及预后评估
Crit Care. 2013 Oct 20;17(5):R244. doi: 10.1186/cc13070.
5
Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study.急诊室中 presepsin 在脓毒症管理中的诊断和预后价值:一项多中心前瞻性研究。
Crit Care. 2013 Jul 30;17(4):R168. doi: 10.1186/cc12847.
6
Can we use C-reactive protein levels to predict severe infection or sepsis in severely burned patients?我们能否使用C反应蛋白水平来预测严重烧伤患者的严重感染或脓毒症?
Int J Burns Trauma. 2013 Jul 8;3(3):137-43. Print 2013.
7
Comparative assessment of cytokines and other inflammatory markers for the early diagnosis of neonatal sepsis-a case control study.比较细胞因子和其他炎症标志物在新生儿败血症早期诊断中的应用——病例对照研究。
PLoS One. 2013 Jul 15;8(7):e68426. doi: 10.1371/journal.pone.0068426. Print 2013.
8
Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients.在美国重症监护病房中,脓毒症患者降钙素原在72小时内下降预示着致命结局。
Crit Care. 2013 Jun 20;17(3):R115. doi: 10.1186/cc12787.
9
CD64 as a potential biomarker in septic arthritis.CD64 作为脓毒性关节炎的潜在生物标志物。
BMC Infect Dis. 2013 Jun 19;13:278. doi: 10.1186/1471-2334-13-278.
10
Rapid diagnosis of bloodstream infections with PCR followed by mass spectrometry.采用聚合酶链反应(PCR)结合质谱分析法快速诊断血流感染
PLoS One. 2013 Apr 23;8(4):e62108. doi: 10.1371/journal.pone.0062108. Print 2013.